Literature DB >> 16813894

Efficiency of questionnaires used to screen for interstitial cystitis.

Leslie Kushner1, Robert M Moldwin.   

Abstract

PURPOSE: Questionnaires for the evaluation of interstitial cystitis are widely used, but their value in discriminating interstitial cystitis from other diagnoses among patients with urological symptoms has not been determined. We assessed the validity of 2 frequently used interstitial cystitis questionnaires-the O'Leary-Sant Symptom Index and Problem Index and the Pain, Urgency, Frequency Symptom Scale-for screening for interstitial cystitis.
MATERIALS AND METHODS: The Pain, Urgency, Frequency Symptom Scale and the O'Leary-Sant Symptom Index and Problem Index were administered to the same 220 patients at a urology clinic before diagnosis. Questionnaire scores between patients with and without interstitial cystitis, as well as among diagnostic groups, were compared by parametric and nonparametric analyses. Receiver operating characteristic curves were constructed to determine the efficiency of each questionnaire in discriminating between patients with and without interstitial cystitis.
RESULTS: Interstitial cystitis was distinguishable from the other diagnoses using both questionnaires (p <0.001). Separate analyses of bother and symptom scores yielded similar results. Receiver operating characteristic curves demonstrated the Pain, Urgency, Frequency Symptom Scale to be more efficient than the O'Leary-Sant Symptom Index and Problem Index in detecting interstitial cystitis in this population with an optimal cutoff value of 13 or greater.
CONCLUSIONS: While the Pain, Urgency, Frequency Symptom Scale and the O'Leary-Sant Symptom Index and Problem Index questionnaires distinguish interstitial cystitis from other urinary tract pathologies, neither questionnaire demonstrates sufficient specificity to serve as the sole diagnostic indicator. These questionnaires should not be used to define interstitial cystitis, but can be used to screen patients with urinary tract symptoms to identify those who should be further examined for interstitial cystitis or to follow those who have already been diagnosed.

Entities:  

Mesh:

Year:  2006        PMID: 16813894     DOI: 10.1016/j.juro.2006.03.035

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  15 in total

1.  Diagnosis of interstitial cystitis June 2007.

Authors:  Lesley K Carr; Jacques Corcos; J Curtis Nickel; Joel Teichman
Journal:  Can Urol Assoc J       Date:  2009-02       Impact factor: 1.862

Review 2.  Interstitial cystitis/bladder pain syndrome: diagnosis and management.

Authors:  I Offiah; S B McMahon; B A O'Reilly
Journal:  Int Urogynecol J       Date:  2013-02-22       Impact factor: 2.894

3.  CUA guideline: Diagnosis and treatment of interstitial cystitis/bladder pain syndrome.

Authors:  Ashley Cox; Nicole Golda; Genevieve Nadeau; J Curtis Nickel; Lesley Carr; Jacques Corcos; Joel Teichman
Journal:  Can Urol Assoc J       Date:  2016-05-12       Impact factor: 1.862

4.  Diagnosis of interstitial cystitis/bladder pain syndrome in women with chronic pelvic pain: a prospective observational study.

Authors:  Claudia Cheng; Anna Rosamilia; Martin Healey
Journal:  Int Urogynecol J       Date:  2012-03-08       Impact factor: 2.894

5.  Urodynamic testing and interstitial cystitis/painful bladder syndrome.

Authors:  Deeptha N Sastry; Krystal M Hunter; Kristene E Whitmore
Journal:  Int Urogynecol J       Date:  2009-10-16       Impact factor: 2.894

6.  Intravesical lignocaine in the diagnosis of bladder pain syndrome.

Authors:  Rajesh Taneja
Journal:  Int Urogynecol J       Date:  2010-03       Impact factor: 2.894

Review 7.  Paediatric painful bladder syndrome/interstitial cystitis: diagnosis and treatment.

Authors:  Jason Sea; Joel M H Teichman
Journal:  Drugs       Date:  2009       Impact factor: 9.546

8.  Decreased nanobacteria levels and symptoms of nanobacteria-associated interstitial cystitis/painful bladder syndrome after tetracycline treatment.

Authors:  Qing-hua Zhang; Xue-cheng Shen; Zhan-song Zhou; Zhi-wen Chen; Gen-sheng Lu; Bo Song
Journal:  Int Urogynecol J       Date:  2009-09-17       Impact factor: 2.894

9.  Clinical Remission Using Personalized Low-Dose Intravenous Infusions of N-acetylcysteine with Minimal Toxicities for Interstitial Cystitis/Bladder Pain Syndrome.

Authors:  Dipnarine Maharaj; Gayathri Srinivasan; Sarah Makepeace; Christopher J Hickey; Jacqueline Gouvea
Journal:  J Pers Med       Date:  2021-04-24

10.  Specific and number of comorbidities are associated with increased levels of temporomandibular pain intensity and duration.

Authors:  Haissam Dahan; Yoram Shir; Ana Velly; Paul Allison
Journal:  J Headache Pain       Date:  2015-05-20       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.